Medicamento para Alzheimer inicial come�a a ser vendido no Brasil
AI Summary
The long-awaited Leqembi, a medication for early-stage Alzheimer's disease, has started selling in Brazil. This marks a significant step forward in the treatment options for Alzheimer's patients in the country. Developed by Eisai and Biogen, Leqembi offers a new hope for those affected by the disease, potentially slowing its progression. This development is crucial as Alzheimer's continues to be a major public health challenge, especially in aging populations.
Original Source
Read the full article at Redir →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.